[go: up one dir, main page]

DE69122858D1 - Therapeutische benzazepin verbindungen - Google Patents

Therapeutische benzazepin verbindungen

Info

Publication number
DE69122858D1
DE69122858D1 DE69122858T DE69122858T DE69122858D1 DE 69122858 D1 DE69122858 D1 DE 69122858D1 DE 69122858 T DE69122858 T DE 69122858T DE 69122858 T DE69122858 T DE 69122858T DE 69122858 D1 DE69122858 D1 DE 69122858D1
Authority
DE
Germany
Prior art keywords
treatment
therapeutic
formula
neurological disorders
benzazepine compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69122858T
Other languages
English (en)
Other versions
DE69122858T2 (de
Inventor
Marc Chapdelaine
Charles Mclaren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca UK Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of DE69122858D1 publication Critical patent/DE69122858D1/de
Application granted granted Critical
Publication of DE69122858T2 publication Critical patent/DE69122858T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69122858T 1991-01-02 1991-12-30 Therapeutische benzazepin verbindungen Expired - Fee Related DE69122858T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919100028A GB9100028D0 (en) 1991-01-02 1991-01-02 Compounds
PCT/GB1991/002326 WO1992011854A1 (en) 1991-01-02 1991-12-30 Therapeutic benzazepine compounds

Publications (2)

Publication Number Publication Date
DE69122858D1 true DE69122858D1 (de) 1996-11-28
DE69122858T2 DE69122858T2 (de) 1997-02-20

Family

ID=10687882

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69122858T Expired - Fee Related DE69122858T2 (de) 1991-01-02 1991-12-30 Therapeutische benzazepin verbindungen

Country Status (22)

Country Link
US (3) US5254683A (de)
EP (1) EP0517876B1 (de)
JP (1) JP3034604B2 (de)
KR (1) KR100229049B1 (de)
AT (1) ATE144423T1 (de)
AU (1) AU650086B2 (de)
CA (1) CA2058593A1 (de)
CZ (1) CZ299292A3 (de)
DE (1) DE69122858T2 (de)
DK (1) DK0517876T3 (de)
ES (1) ES2093246T3 (de)
FI (1) FI104071B1 (de)
GB (2) GB9100028D0 (de)
GR (1) GR3021440T3 (de)
HU (2) HU212269B (de)
IE (1) IE920009A1 (de)
IL (1) IL100484A (de)
NO (1) NO300497B1 (de)
NZ (1) NZ241197A (de)
PL (1) PL166481B1 (de)
WO (1) WO1992011854A1 (de)
ZA (1) ZA9223B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9100028D0 (en) * 1991-01-02 1991-02-20 Ici Plc Compounds
GB9212308D0 (en) * 1992-06-10 1992-07-22 Ici Plc Therapeutic compositions
CA2138026C (en) * 1992-06-22 2003-09-09 Eckard Weber Novel 1,4-dihydroquinoxaline-2,3-diones and uses therefor as glycine receptor antagonists
US5834479A (en) * 1993-03-05 1998-11-10 Mayer; David J. Method and composition for alleviating pain
CA2115792C (en) 1993-03-05 2005-11-01 David J. Mayer Method for the treatment of pain
GB9311948D0 (en) * 1993-06-10 1993-07-28 Zeneca Ltd Substituted nitrogen heterocycles
US5801168A (en) * 1994-06-09 1998-09-01 Zeneca Limited Substituted nitrogen heterocycles
US5476933A (en) * 1994-11-16 1995-12-19 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Azepine synthesis via a diels-alder reaction
FR2796552A1 (fr) * 1999-07-21 2001-01-26 Centre Nat Rech Scient Nouvelle utilisation de derives de la beta-naphtoquinone et de leurs sels pour la fabrication de medicaments exercant un effet inhibiteur sur la liberation de glutamate dans le cerveau
JP4989830B2 (ja) * 1999-07-21 2012-08-01 サーントゥル ナシオナル ドゥ ラ ルシェルシュ シャーンティフィク 脳によるグルタミン酸塩の放出に対して抑制効果を示す薬剤を製造するためのベータ−ナフトキノン誘導体の使用
JPWO2016199789A1 (ja) * 2015-06-08 2018-03-29 国立大学法人名古屋大学 トリフルオロメチル置換セミスクアレートの製造方法、トリフルオロメチル置換セミスクアレートを起点とするトリフルオロメチル化合物の製造方法及びトリフルオロメチル基含有化合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1340334A (en) * 1970-07-06 1973-12-12 Rees A H Synthesis of benzazetropolones and hence of kynurenic acids
EP0072352B1 (de) * 1981-08-11 1986-03-05 Ciba-Geigy Ag Benzazepin-2-one, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese Verbindungen enthalten, sowie die Verbindungen zur therapeutischen Verwendung
US4410520A (en) * 1981-11-09 1983-10-18 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4473575A (en) * 1982-07-19 1984-09-25 Ciba-Geigy Corporation 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
US4575503A (en) * 1983-02-10 1986-03-11 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4477446A (en) * 1983-07-01 1984-10-16 Usv Pharmaceutical Corporation 1-Benzazepines and their pharmaceutical uses
DE3416695A1 (de) * 1984-05-05 1985-11-07 Bayer Ag, 5090 Leverkusen Amidinohydrazone von tetralin-, chromon-, thiochromon- und tretrahydrochinolin-derivaten, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE69026708T2 (de) * 1989-10-20 1997-04-03 Otsuka Pharma Co Ltd Benzoheterozyklische verbindungen
GB9100028D0 (en) * 1991-01-02 1991-02-20 Ici Plc Compounds
CA2138026C (en) * 1992-06-22 2003-09-09 Eckard Weber Novel 1,4-dihydroquinoxaline-2,3-diones and uses therefor as glycine receptor antagonists

Also Published As

Publication number Publication date
HU9202618D0 (en) 1992-10-28
IL100484A (en) 1997-02-18
HUT64309A (en) 1993-12-28
WO1992011854A1 (en) 1992-07-23
PL166481B1 (en) 1995-05-31
ES2093246T3 (es) 1996-12-16
GB2251616B (en) 1995-01-11
EP0517876A1 (de) 1992-12-16
AU9134091A (en) 1992-08-17
NZ241197A (en) 1994-10-26
EP0517876B1 (de) 1996-10-23
AU650086B2 (en) 1994-06-09
FI923759L (fi) 1992-08-20
US5541319A (en) 1996-07-30
FI923759A0 (fi) 1992-08-20
GB2251616A (en) 1992-07-15
GR3021440T3 (en) 1997-01-31
FI104071B (fi) 1999-11-15
CA2058593A1 (en) 1992-07-03
IE920009A1 (en) 1992-07-15
IL100484A0 (en) 1992-09-06
KR100229049B1 (ko) 1999-11-01
GB9127498D0 (en) 1992-02-19
NO923413D0 (no) 1992-09-01
CZ299292A3 (en) 1993-01-13
NO923413L (no) 1992-09-01
DK0517876T3 (da) 1997-04-01
HU211466A9 (en) 1995-11-28
US5446039A (en) 1995-08-29
NO300497B1 (no) 1997-06-09
JP3034604B2 (ja) 2000-04-17
ATE144423T1 (de) 1996-11-15
US5254683A (en) 1993-10-19
FI104071B1 (fi) 1999-11-15
GB9100028D0 (en) 1991-02-20
PL295932A1 (en) 1993-10-04
ZA9223B (en) 1992-09-30
HU212269B (en) 1996-07-29
DE69122858T2 (de) 1997-02-20
JPH07502007A (ja) 1995-03-02

Similar Documents

Publication Publication Date Title
MY109737A (en) Treatment and compounds.
DE3260529D1 (en) Therapeutically useful 1-alkyl-2-aminotetralin derivatives
ATE144423T1 (de) Therapeutische benzazepin verbindungen
MXPA02001571A (es) Metodo de tratamiento para el cancer.
NO923199D0 (no) Terapeutiske forbindelser
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
DK0510748T3 (da) Anvendelse af en methoxyalkansyre af indazol til fremstilling af et lægemiddel til behandling af autoimmune sygdomme
ATE5961T1 (de) N-acylpeptid-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ZA922625B (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
MY108455A (en) Therapeutic benzazapine compounds.
PT100641A (pt) Processo de tratamento com benzazepinas, composicoes farmaceuticas que contem estas benzazepinas, compostos benzazepinicos e processo para a sua preparacao
KR950700063A (ko) 외상후 스트레스 치료제로서의 브로파로민(Brofaromine as an agent for treating post-traumatic stress)
JPS57176910A (en) Medicinal composition
TH19066A (th) วิธีสำหรับยับยั้งการเพิ่มจำนวนเซลล์กล้ามเนื้อเรียบและภาวะการตีบของหลอดเลือด

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ASTRAZENECA UK LTD., LONDON, GB

8339 Ceased/non-payment of the annual fee